Femara 2.5mg, produced by Eurimpharm, is a medication primarily used in the treatment of hormone-receptor-positive breast cancer in postmenopausal women. Its active ingredient, letrozole, belongs to a class of drugs known as aromatase inhibitors. By reducing estrogen levels in the body, Femara helps to slow or stop the growth of certain types of breast tumors […]
Recent Comments